首都医药
首都醫藥
수도의약
CAPITAL MEDICINE
2014年
2期
36-38
,共3页
弥漫性泛细支气管炎%药学监护%大环内酯类药物
瀰漫性汎細支氣管炎%藥學鑑護%大環內酯類藥物
미만성범세지기관염%약학감호%대배내지류약물
Diffuse Panbronchiolitis%Pharmacutical Care%Macrolide
目的:以对一例弥漫性泛细支气管炎病人诊疗的全过程参与和药学监护为例,说明临床药师需要参与对患者完整的医疗过程,不断地了解相关疾病的发生发展机制及相关诊治指南,从而拓展自身更为宽泛的用药思路,以便为用药提供良好的药学支持,并为临床医生提供可靠的药学信息服务。方法阐述临床对弥漫性泛细支气管炎的定义、临床诊断该病的诊断指标和具体的治疗方案。同时,结合我院收治的弥漫性泛细支气管炎患者的病例资料、诊治经过及治疗方案中相关药物的作用机制及使用剂量和临床药师在其中发挥的作用,对弥漫性泛细支气管炎患者的药学监护进行阐述。结果弥漫性泛细支气管炎是一种弥漫存在于两肺的呼吸性细支气管的气道慢性炎症性疾病,且在临床上易与其他慢性气道疾病混淆。而目前我国尚无诊断标准,主要还是参考他国诊断标准。对于治疗方案的选择还要根据患者的病例资料分析情况进行合理选择。结论临床药师在工作中需紧密联系病例的实际情况,熟悉医生的诊疗思路及相关疾病的发生发展机制,治疗进展,诊治指南,为临床提供更为可靠的药学知识及用药思路,更好地指导临床用药方案的制定。
目的:以對一例瀰漫性汎細支氣管炎病人診療的全過程參與和藥學鑑護為例,說明臨床藥師需要參與對患者完整的醫療過程,不斷地瞭解相關疾病的髮生髮展機製及相關診治指南,從而拓展自身更為寬汎的用藥思路,以便為用藥提供良好的藥學支持,併為臨床醫生提供可靠的藥學信息服務。方法闡述臨床對瀰漫性汎細支氣管炎的定義、臨床診斷該病的診斷指標和具體的治療方案。同時,結閤我院收治的瀰漫性汎細支氣管炎患者的病例資料、診治經過及治療方案中相關藥物的作用機製及使用劑量和臨床藥師在其中髮揮的作用,對瀰漫性汎細支氣管炎患者的藥學鑑護進行闡述。結果瀰漫性汎細支氣管炎是一種瀰漫存在于兩肺的呼吸性細支氣管的氣道慢性炎癥性疾病,且在臨床上易與其他慢性氣道疾病混淆。而目前我國尚無診斷標準,主要還是參攷他國診斷標準。對于治療方案的選擇還要根據患者的病例資料分析情況進行閤理選擇。結論臨床藥師在工作中需緊密聯繫病例的實際情況,熟悉醫生的診療思路及相關疾病的髮生髮展機製,治療進展,診治指南,為臨床提供更為可靠的藥學知識及用藥思路,更好地指導臨床用藥方案的製定。
목적:이대일례미만성범세지기관염병인진료적전과정삼여화약학감호위례,설명림상약사수요삼여대환자완정적의료과정,불단지료해상관질병적발생발전궤제급상관진치지남,종이탁전자신경위관범적용약사로,이편위용약제공량호적약학지지,병위림상의생제공가고적약학신식복무。방법천술림상대미만성범세지기관염적정의、림상진단해병적진단지표화구체적치료방안。동시,결합아원수치적미만성범세지기관염환자적병례자료、진치경과급치료방안중상관약물적작용궤제급사용제량화림상약사재기중발휘적작용,대미만성범세지기관염환자적약학감호진행천술。결과미만성범세지기관염시일충미만존재우량폐적호흡성세지기관적기도만성염증성질병,차재림상상역여기타만성기도질병혼효。이목전아국상무진단표준,주요환시삼고타국진단표준。대우치료방안적선택환요근거환자적병례자료분석정황진행합리선택。결론림상약사재공작중수긴밀련계병례적실제정황,숙실의생적진료사로급상관질병적발생발전궤제,치료진전,진치지남,위림상제공경위가고적약학지식급용약사로,경호지지도림상용약방안적제정。
Objective A case of the treatment for an sufferer of diffuse panbronchiolitis was taken to show the necessity for clinical pharmacists participating the whole process of medical treatment and pharmaceutical care,that’s will be helpful to understand what the therapeutic team consider and how to supply better medical and pharmaceutical service.Methods The clinical diagnosis index,the definition of diffuse panbronchiolitis clinical diagnosis of the disease and specific treatment.At the same time,according to our hospital of diffuse panbronchiolitis in patients with clinical data,mechanism of action and the dosage of diagnoses and treatment of medicine and clinical pharmacists in which the role of pharmaceutical care,diffuse panbronchiolitis were referred to.Results Diffuse panbronchiolitis is a diffuse in two lung respiratory bronchioles chronic inflammatory airway disease in clinic,and easily with other chronic airway diseases confusion.At present,there is no diagnostic criteria,mainly referring to his country's diagnostic criteria.For the choice of treatment depends on the clinical data of the patients with the situation of rational choice.Conclusions The clinical pharmacists to actual clinical situation closely related cases in the work,familiar with the diagnosis and treatment of a doctor,familiar with the occurrence and development mechanism,the treatment of related diseases diagnosis and treatment progress,guide,for clinical provides more knowledge of medicine and drug ideas and reliable,making better guide clinical medication.